Prior authorization, step therapy and shifting coverage rules keep patients from obesity drugs with proven benefits, an endocrinologist argues — and the long-term savings make the case for broader access.
Sethu Reddy, M.D.
Advertisement
Sethu Reddy, M.D., is an endocrinologist based in Michigan. He previously served as Chair of Endocrinology, Diabetes and Metabolism at Cleveland Clinic and currently acts as Professor and Senior Associate Dean of Research at Covenant HealthCare College of Medicine at Central Michigan University.
Articles by Sethu Reddy, M.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Medical Economics
1
ACOs are 'the best way to deliver health care,' CMS chief Dr. Oz says
2
NPs are registering new practices at nearly 6 times the 2019 rate
3
Veterans with essential tremor can now get a nondrug wearable device through the VA
4
As Medicare’s new ACO model begins, kidney care cannot be left behind
5